Clareo Health | Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
T. John Winhusen, PhD
With
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
This is an intent-to-treat, two-arm, open-label, randomized controlled trial. Eligible participants will be randomized in a 1:1 ratio to TOME or Control, balancing on site. Participants will receive the assigned intervention following randomization and will complete a three week follow-up assessment.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Potential participants must be:
1. 18 years of age or older;
2. Pregnant or be within 12 months postpartum;
3. Enrolled in MOUD (either buprenorphine or methadone) at the study site or affiliated clinic where enrollment can be confirmed;
4. Able to understand the study, and having understood, provide written informed consent in English
You may not be if
Potential participants must not:
1\. have suicidal or homicidal ideation requiring immediate attention.
